Niemann-Pick Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
Condition: Niemann-Pick Disease, Type C Intervention: Drug: Adrabetadex Sponsor: Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2021 Category: Research Source Type: clinical trials
